Divide and Conquer
Cambridge
About Divide and Conquer
Divide & Conquer is a biotechnology company based in Cambridge, UK and working in collaboration with the University of Heidelberg and German Cancer Research Center (DKFZ). The company is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumours with very poor life expectancy. Divide & Conquer is funded by VC firm Medicxi.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $12.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2019)
- Website: conquer.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital, Oncology
Social Profiles
Canonical: https://fsome.com/organization/divide-and-conquer-45273 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.